Trajan Group

Executive Summary

Trajan Scientific and Medical (Trajan Group) is a publicly listed Australian company that designs and manufactures precision analytical components and life-science devices. Its core offerings include chromatography and mass spectrometry consumables, microsampling kits, automated fluidic systems, and integrated laboratory workflows. Trajan serves health, food, and environmental markets, with a strong emphasis on sample integrity and high-throughput automation. The company’s microsampling technology, which enables blood collection from a finger prick, positions it as a key player in decentralized diagnostics and remote patient monitoring. Trajan also provides original equipment manufacturer (OEM) components to leading analytical instrument makers, giving it a diversified revenue base across consumables and systems. Financially, Trajan has demonstrated consistent revenue growth driven by its consumables-heavy business model and expansion in the pharmaceutical and clinical diagnostics sectors. The company has invested in manufacturing capacity and R&D to accelerate product innovation, particularly in automation and microsampling. Recent strategic partnerships with global diagnostic firms and contract wins for its automated sample preparation platforms underscore its competitive differentiation. While near-term headwinds include macroeconomic pressures on lab spending, Trajan’s recurring revenue from consumables and its exposure to growing trends like personalized medicine and point-of-care testing support a positive long-term outlook. The company’s focus on high-margin consumables and automation aligns with industry shifts toward efficiency and decentralization.

Upcoming Catalysts (preview)

• Q3 2026FDA Clearance for Next-Generation Microsampling Device65% success
• Q4 2026Major OEM Partnership for High-Throughput Automation Platform70% success
• Q1 2027Launch of Expanded Chromatography Consumables Portfolio80% success